Faculty Research in the News
Stem Cell Research
- Posted on February 07, 2006
Princeton NJ — Long before “superman” Christopher Reeve’s spinal cord injury and actor Michael J. Fox’s Parkinson’s disease fueled the public fervor over regenerative therapies, Princeton scientists were making breakthroughs in stem cell research.
It was only natural that Princeton researchers would make the list when New Jersey became the first state in December of last year to award grants for work on stem cells.
Two of the University’s grant recipients, molecular biologists Ihor Lemischka and Kateri Moore, continue exploring the cutting edge of stem cell research. One of these efforts is a collaboration with electrical engineer Ron Weiss to program embryonic stem cells to “fix” disease. The third grant recipient, molecular biologist Thomas Shenk, will focus on producing stem cells from human umbilical cord blood.
The grants from the New Jersey Commission on Science and Technology will further work in the field of stem cell advancements that began at Princeton more than 25 years ago.
Still, the current public interest in their work creates challenges for Princeton researchers unseen in past decades. Rampant misinformation about the progress of stem cell research affects funding and raises the need for public education. Read More